{"id":1936,"date":"2025-12-01T05:39:32","date_gmt":"2025-12-01T05:39:32","guid":{"rendered":"https:\/\/www.pk-pharmakommunikation.de\/?p=1936"},"modified":"2025-12-01T05:39:32","modified_gmt":"2025-12-01T05:39:32","slug":"when-thinking-thinks-until-there-is-nothing-left-to-think","status":"publish","type":"post","link":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/","title":{"rendered":"When \u201cthinking\u201d thinks until there is nothing left to&nbsp;think"},"content":{"rendered":"<p>Just in time for our final review of the year, we at the agency are taking another look back at what\u2019s new so far. One of the topics we\u2019ve been discussing is ChatGTP and the new Thinking Mode. Could it make everything better? Is there more to AI than suggesting shortenings and checking for spelling and grammar mistakes? Could our virtual colleague even write the basis for an entire professional article\u2014without any hallucinations?<\/p>\n<p><b>In practice, it looks like&nbsp;this:<\/b><\/p>\n<p>The test run starts off well thought out. We write a detailed prompt, define the target audience, topic, tone, and length. Of course, we put a lot of effort into this, because we wanted to be able to continue working with the results.<\/p>\n<p>Then we wait. Until now, neither the statements nor the sources provided by the AI could be trusted. Our eager colleague ChatGTP likes to make things up to make herself look better. This shouldn\u2019t happen anymore in the Thinking mode. We are excited to see the result. But then what happens is<\/p>\n<p><b>Silence. Abort. End.<\/b><\/p>\n<p>Either the text breaks off in the middle or, even better, <b>nothing<\/b> appears\u2014Thinking Mode thinks and thinks, and in the end, there is nothing. No sentence, no fragment. And even the sentence \u201cPlease finish writing this text\u201d doesn\u2019t work. Because the beginning has long since vanished into virtual fog.<\/p>\n<p><b>Why the thinking mode sometimes \u201cstrays\u201d<\/b><\/p>\n<p>In theory, the thinking mode is a blessing, because it actually follows instructions such as \u201cdon\u2019t estimate the word count, just count\u201d or \u201cdon\u2019t interpret the results, just reproduce what is actually there.\u201d The problem: additional \u201cthinking work\u201d requires resources. It costs computing time, and on top of that, each answer has a limited \u201cword budget\u201d (number of tokens). If this budget is exceeded or the calculation takes too long, it\u2019s game over \u2013 the technology says, \u201cTime\u2019s up.\u201d<\/p>\n<p>For us, this feels like a download that stops at 98%\u2014painful for our time budget, emotionally\u2026 let\u2019s say: not good for our blood pressure.<\/p>\n<p><b>Avoiding blackout experiences<\/b><\/p>\n<p>At the end of the day, we\u2019ve at least made some progress with&nbsp;this:<\/p>\n<ul>\n<li>Outline first, text later: First, just create a structure: headings, subchapters, rough bullet points.<\/li>\n<li>Formulate in stages: Each section gets its own prompt \u2013 like individual building blocks for layout and approval. This way, the entire text can\u2019t disappear before anything even lands on the screen.<\/li>\n<li>Limit the mental effort: Don\u2019t make too many demands at once. What can be done one after the other should also be done one after the other. Formulate as \u201cfoolproof\u201d as possible and, if necessary, simply ask the AI itself why it did something a certain way. At least it helps for the future\u2026<\/li>\n<\/ul>\n<p>ChatGPT is not an author, but a structural aid, a wording machine, or a source of ideas for variations, subheadings, and introductions. What it definitely does not replace: a knowledgeable author. In any case, we prefer to let AI continue to do the smaller auxiliary tasks \u2013 that saves time and doesn\u2019t waste&nbsp;it.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Just in time for our final review of the year, we at the agency are taking another look back at what\u2019s new so far. One of the topics we\u2019ve been discussing is ChatGTP and the new Thinking Mode. Could it make everything better? Is there more to AI than suggesting shortenings and checking for spelling&nbsp;[\u2026]<\/p>\n","protected":false},"author":4,"featured_media":1938,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[20,11],"tags":[],"class_list":["post-1936","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-en","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>When \u201cthinking\u201d thinks until there is nothing left to think &#8226; PK Pharmakommunikation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"When \u201cthinking\u201d thinks until there is nothing left to think &#8226; PK Pharmakommunikation\" \/>\n<meta property=\"og:description\" content=\"Just in time for our final review of the year, we at the agency are taking another look back at what\u2019s new so far. One of the topics we\u2019ve been discussing is ChatGTP and the new Thinking Mode. Could it make everything better? Is there more to AI than suggesting shortenings and checking for spelling [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/\" \/>\n<meta property=\"og:site_name\" content=\"PK Pharmakommunikation\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-01T05:39:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pk-pharmakommunikation.de\/wp-content\/uploads\/desk-1283688_1280.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Elke\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Elke\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/\"},\"author\":{\"name\":\"Elke\",\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/#\\\/schema\\\/person\\\/c09686d559e7fc144b0cde96970f2313\"},\"headline\":\"When \u201cthinking\u201d thinks until there is nothing left to&nbsp;think\",\"datePublished\":\"2025-12-01T05:39:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/\"},\"wordCount\":528,\"publisher\":{\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/wp-content\\\/uploads\\\/desk-1283688_1280.jpg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/\",\"url\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/\",\"name\":\"When \u201cthinking\u201d thinks until there is nothing left to think &#8226; PK Pharmakommunikation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/wp-content\\\/uploads\\\/desk-1283688_1280.jpg\",\"datePublished\":\"2025-12-01T05:39:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/wp-content\\\/uploads\\\/desk-1283688_1280.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/wp-content\\\/uploads\\\/desk-1283688_1280.jpg\",\"width\":1280,\"height\":853},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/blog\\\/when-thinking-thinks-until-there-is-nothing-left-to-think\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"When \u201cthinking\u201d thinks until there is nothing left to think\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/\",\"name\":\"PK Pharmakommunikation\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/#organization\",\"name\":\"PK Pharmakommunikation\",\"url\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/wp-content\\\/uploads\\\/pk-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/wp-content\\\/uploads\\\/pk-logo.svg\",\"width\":566,\"height\":160,\"caption\":\"PK Pharmakommunikation\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pk-pharmakommunikation.de\\\/en\\\/#\\\/schema\\\/person\\\/c09686d559e7fc144b0cde96970f2313\",\"name\":\"Elke\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"When \u201cthinking\u201d thinks until there is nothing left to think &#8226; PK Pharmakommunikation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/","og_locale":"en_US","og_type":"article","og_title":"When \u201cthinking\u201d thinks until there is nothing left to think &#8226; PK Pharmakommunikation","og_description":"Just in time for our final review of the year, we at the agency are taking another look back at what\u2019s new so far. One of the topics we\u2019ve been discussing is ChatGTP and the new Thinking Mode. Could it make everything better? Is there more to AI than suggesting shortenings and checking for spelling [&hellip;]","og_url":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/","og_site_name":"PK Pharmakommunikation","article_published_time":"2025-12-01T05:39:32+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/www.pk-pharmakommunikation.de\/wp-content\/uploads\/desk-1283688_1280.jpg","type":"image\/jpeg"}],"author":"Elke","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Elke","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/#article","isPartOf":{"@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/"},"author":{"name":"Elke","@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/#\/schema\/person\/c09686d559e7fc144b0cde96970f2313"},"headline":"When \u201cthinking\u201d thinks until there is nothing left to&nbsp;think","datePublished":"2025-12-01T05:39:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/"},"wordCount":528,"publisher":{"@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/#organization"},"image":{"@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pk-pharmakommunikation.de\/wp-content\/uploads\/desk-1283688_1280.jpg","articleSection":["Blog"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/","url":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/","name":"When \u201cthinking\u201d thinks until there is nothing left to think &#8226; PK Pharmakommunikation","isPartOf":{"@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/#primaryimage"},"image":{"@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pk-pharmakommunikation.de\/wp-content\/uploads\/desk-1283688_1280.jpg","datePublished":"2025-12-01T05:39:32+00:00","breadcrumb":{"@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/#primaryimage","url":"https:\/\/www.pk-pharmakommunikation.de\/wp-content\/uploads\/desk-1283688_1280.jpg","contentUrl":"https:\/\/www.pk-pharmakommunikation.de\/wp-content\/uploads\/desk-1283688_1280.jpg","width":1280,"height":853},{"@type":"BreadcrumbList","@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/blog\/when-thinking-thinks-until-there-is-nothing-left-to-think\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pk-pharmakommunikation.de\/en\/"},{"@type":"ListItem","position":2,"name":"When \u201cthinking\u201d thinks until there is nothing left to think"}]},{"@type":"WebSite","@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/#website","url":"https:\/\/www.pk-pharmakommunikation.de\/en\/","name":"PK Pharmakommunikation","description":"","publisher":{"@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pk-pharmakommunikation.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/#organization","name":"PK Pharmakommunikation","url":"https:\/\/www.pk-pharmakommunikation.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.pk-pharmakommunikation.de\/wp-content\/uploads\/pk-logo.svg","contentUrl":"https:\/\/www.pk-pharmakommunikation.de\/wp-content\/uploads\/pk-logo.svg","width":566,"height":160,"caption":"PK Pharmakommunikation"},"image":{"@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.pk-pharmakommunikation.de\/en\/#\/schema\/person\/c09686d559e7fc144b0cde96970f2313","name":"Elke"}]}},"_links":{"self":[{"href":"https:\/\/www.pk-pharmakommunikation.de\/en\/wp-json\/wp\/v2\/posts\/1936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pk-pharmakommunikation.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pk-pharmakommunikation.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pk-pharmakommunikation.de\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pk-pharmakommunikation.de\/en\/wp-json\/wp\/v2\/comments?post=1936"}],"version-history":[{"count":1,"href":"https:\/\/www.pk-pharmakommunikation.de\/en\/wp-json\/wp\/v2\/posts\/1936\/revisions"}],"predecessor-version":[{"id":1939,"href":"https:\/\/www.pk-pharmakommunikation.de\/en\/wp-json\/wp\/v2\/posts\/1936\/revisions\/1939"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pk-pharmakommunikation.de\/en\/wp-json\/wp\/v2\/media\/1938"}],"wp:attachment":[{"href":"https:\/\/www.pk-pharmakommunikation.de\/en\/wp-json\/wp\/v2\/media?parent=1936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pk-pharmakommunikation.de\/en\/wp-json\/wp\/v2\/categories?post=1936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pk-pharmakommunikation.de\/en\/wp-json\/wp\/v2\/tags?post=1936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}